# CASPOFUNGIN ACETATE
> **ANDA207092** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-09-29
## Drug
- **FDA Application Number:** ANDA207092
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CASPOFUNGIN ACETATE
- **Generic name:** CASPOFUNGIN ACETATE
- **Active ingredients:** CASPOFUNGIN ACETATE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2017-09-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207092)
---
*AI Analytics · CC0 1.0*